Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
08.09.19 | Ipsen and Servier announce initial Phase II/III clinical data evaluating investigational liposomal irinotecan (ONIVYDE) as a second-line treatment for small cell lung cancer (SCLC) at the IASLC 2019 World Conference on Lung Cancer | 903 | Business Wire | 44% of patients achieved a response and nearly half (48%) maintained disease control at week 12 (efficacy as secondary endpoint)
Treatment emergent adverse events Grade 3 or higher were reported... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NVIDIA | 5.794 |
EVOTEC | 3.221 |
NEL | 2.008 |
PLUG POWER | 1.690 |
TUI | 1.567 |
GAMESTOP | 1.461 |
BIONTECH | 1.332 |
BAYER | 1.029 |
JINKOSOLAR | 966 |
RHEINMETALL | 831 |
MERCEDES-BENZ | 748 |
SUPER MICRO COMPUTER | 722 |
VOLKSWAGEN | 714 |
TESLA | 702 |
CUREVAC | 657 |
AIXTRON SE | 647 |
DEUTSCHE LUFTHANSA | 642 |
SIEMENS ENERGY | 621 |
BYD | 604 |
RENK GROUP | 587 |
COMMERZBANK | 580 |
DEUTSCHE BANK | 565 |
PORSCHE AG | 560 |
MICROSOFT | 538 |
REDCARE PHARMACY | 531 |